Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Integer Holdings (ITGR)

Integer Holdings: Cardiac president Jim Stephens moves to special projects role through March 2027

Neutral Impact 3 of 5 leadership Written later

Integer Holdings said its President of Cardiac Rhythm Management & Neuromodulation, Jim Stephens, will become Executive Vice President, Special Projects, effective June 29, 2026. The new role is set to end March 31, 2027, and he will not receive a 2027 short-term or long-term incentive award. The filing is a leadership transition with limited direct financial figures, but it removes a business unit president from his current role.

Key points

  • Jim Stephens moves from President, Cardiac Rhythm Management & Neuromodulation to Executive Vice President, Special Projects, effective June 29, 2026.
  • The new role ends on March 31, 2027, unless terminated earlier by Mr. Stephens or the Company.
  • Mr. Stephens will not be eligible for a 2027 short-term or long-term incentive award.
  • If a change of control occurs on or before March 31, 2027 and he remains employed through that date, his separation will be treated as a termination without Cause under his Change of Control Agreement dated May 22, 2026.

The filing

CompanyInteger Holdings (ITGR)
Form8-K, current report
Filed with the SECJun 26, 2026, 4:18 PM ET
Accession number0001114483-26-000024

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.